Actively Recruiting
Environmental Risk Factors for the Anti-synthetase Syndrome
Led by National Institute of Environmental Health Sciences (NIEHS) · Updated on 2026-05-05
580
Participants Needed
8
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: * Like other complex diseases, autoimmune diseases are the result of numerous causes, including genetic and environmental factors. Some researchers believe that people who are susceptible to autoimmune disorders develop them when the body reacts to environmental or other factors by creating white blood cells that attack the body s own tissues, which then progresses to autoimmune diseases. These immune-triggered disorders can overlap with one another to some extent, but most autoimmune diseases have certain distinct triggers. * The autoimmune disorder myositis weakens the muscles and may cause other health problems. Environmental exposures associated with myositis include ultraviolet radiation, stressful life events and muscle overexertion, collagen implants, infections such as retroviruses and streptococci bacteria, and certain drugs and chemicals. Some individuals with myositis also produce proteins in the blood called autoantibodies that react with certain parts of the person s own cells, called synthetases, which are involved in making new proteins. A syndrome called the anti-synthetase syndrome, which includes myositis and lung disease, is associated with having the anti-synthetase autoantibodies. Researchers are interested in studying differences in environmental exposures in individuals with myositis. This study is being conducted to determine if persons with the anti-synthetase syndrome have had different environmental exposures before disease onset compared with other patients with myositis who do not have this syndrome and also compared with healthy volunteers. Objectives: \- To determine whether selected infectious and noninfectious environmental exposures are more common in individuals who have myositis with the anti-synthetase syndrome, compared with healthy volunteers. Eligibility: \- Individuals who have been diagnosed with myositis (with or without anti-synthetase autoantibodies), and healthy volunteers without autoimmune disorders. Design: * Participants will be screened with a full medical history and physical examination, and will provide blood, urine and house dust samples. * Participants will complete questionnaires about their medical history and the types of exposures they have had at work, at home, and elsewhere. Participants who have myositis will also be asked about certain infections, heavy exercise or physical exertion, sun exposure, tobacco and alcohol use, and stressful events prior to being diagnosed with the disease. Healthy volunteers will be asked about the same exposures before the date of diagnosis of disease of the myositis subject to which they have been matched. * Participants will receive a kit that contains instructions and a filter to be put onto their vacuum cleaner to collect house dust in the bedroom. This dust will be kept for possible future analyses of infectious or toxic agents based on the other results from the study. * Individuals with myositis will have other tests as clinically indicated, including lung function tests and imaging studies.
CONDITIONS
Official Title
Environmental Risk Factors for the Anti-synthetase Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with possible, probable, or definite polymyositis or dermatomyositis within 24 months
- Chest X-ray performed if clinically indicated to assess lung disease
- Children must be older than 2 years
- Able and willing to give informed consent, complete questionnaires, and donate blood samples
- Controls matched by race, gender, and age, living near the patient, without autoimmune disease or lung disease
- Controls able and willing to give informed consent, complete questionnaires, and donate blood samples
You will not qualify if you...
- Cancer-associated myositis diagnosed within 2 years
- Inclusion body myositis
- Myositis caused by drugs, toxins, or exposures that resolved after stopping the agent
- Children younger than 2 years
- Medical conditions preventing safe study participation
- Cognitive impairment
- Unable or unwilling to give informed consent or assent
- Not residing in the US or Canada at reference date
- Currently incarcerated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
University of Miami Hospital
Miami, Florida, United States, 33101
Withdrawn
2
Johns Hopkins University
Baltimore, Maryland, United States, 21205
Completed
3
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
4
Mid-Atlantic Kaiser Permanente
Rockville, Maryland, United States, 20853
Completed
5
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Completed
6
Mayo Clinic, Rochester
Rochester, Minnesota, United States, 55905
Completed
7
NIEHS Clinical Research Unit (CRU)
Research Triangle Park, North Carolina, United States, 27709
Actively Recruiting
8
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261
Completed
Research Team
A
Adam I Schiffenbauer, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here